In This Issue: Improving Opioid Safety
Increasing Dental Stewardship of Antibiotics and Opioids
Antibiotics and opioids are the top therapeutic categories prescribed by dentists. Preliminary data gathered by study investigators on dental prescribing demonstrates that:
This gap is significant because dentists prescribe 1 out of every 10 prescriptions for both antibiotics and opioids in the US. Although efforts are increasing to curtail overuse of these medication classes, most interventions are focused on medical providers. Thus, the goal of this ongoing HSR&D study (2018–2022) is to develop actionable findings for decision-makers that can be implemented to improve evidence-based prescribing of antibiotics and opioids by dentists. The aims of this study are to:
Study investigators will use VA administrative data to assess antibiotic and opioid dental prescribing based on American Dental Association recommendations, and will work to identify factors related to prescribing. One-on-one qualitative interviews with 'high-' and 'low'-prescribing dentists at 'high-' and 'low'-prescribing facilities will assess perceptions of antibiotic and opioid prescribing, adverse drug events, as well as facilitators and barriers to the use of prescribing resources. This study’s operational partners include VA Dentistry, VA MedSafe, and the Antimicrobial Stewardship Task Force, representing the first collaboration between these partners.
Principal Investigator: Katie Suda, PharmD, MS, is part of HSR&D’s Center of Innovation for Complex Chronic Healthcare (CINICHH) in Hines, IL.
Publications: Koppen L, Suda KJ, Rowan S, McGregor J, Evans CT. “Dentist prescribing of antibiotics and opioids to Medicare Part D beneficiaries: Medications of high impact to public health.” Journal of the American Dental Association. 2018;149:721-730.